Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial - Simonneau, G; D’Armini, A M; Ghofrani, H A (Lancet Respir Med, 2016)
et al.